Neuromuscular blocking activity and other pharmacologic properties of various carnitine derivatives.
D000818:Animals; D001001:Anura; D001794:Blood Pressure / Q000187:drug effects*; D002331:Carnitine / Q000494:pharmacology*; D002415:Cats; D002794:Choline / Q000494:pharmacology*; D002802:Cholinesterases / Q000378:metabolism*; D003486:Cyanides / Q000494:pharmacology; D003650:Decamethonium Compounds / Q000494:pharmacology; D003964:Diaphragm / Q000187:drug effects; D004336:Drug Antagonism; D004594:Electrophysiology; D006168:Guinea Pigs; D006584:Hexamethonium Compounds / Q000494:pharmacology; D006801:Humans; D007082:Ileum / Q000187:drug effects; D009469:Neuromuscular Junction / Q000187:drug effects*; D010791:Phrenic Nerve / Q000187:drug effects; D010830:Physostigmine / Q000494:pharmacology; D051381:Rats; D012584:Sciatic Nerve / Q000187:drug effects; D013390:Succinylcholine / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology
D003486:Cyanides; D003650:Decamethonium Compounds; D006584:Hexamethonium Compounds; D010830:Physostigmine; D002802:Cholinesterases; D013390:Succinylcholine; D002794:Choline; D002331:Carnitine; D014403:Tubocurarine